Data as of Dec 11
| -0.59 / -1.13%|
The 22 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 55.60, with a high estimate of 65.28 and a low estimate of 48.14. The median estimate represents a +8.11% increase from the last price of 51.43.
The current consensus among 26 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.